老年WHO III级脑膜瘤辅助放疗的生存获益
基于美国国家癌症数据库254例老年(>60岁)WHO III级脑膜瘤患者,比较手术联合辅助外照射放疗与单纯手术的总体生存。多因素分析显示辅助放疗与更长OS相关(AHR 0.663,95%CI 0.449-0.978,P=0.038),但倾向评分匹配后无显著获益(P=0.271)。全切除患者辅助放疗未改善OS(AHR 0.764,95%CI 0.434-1.344,P=0.350)。
要点
- 老年WHO III级脑膜瘤全切除后辅助放疗未显示生存获益。
- 多因素分析辅助放疗与更长OS相关,但倾向匹配后无显著差异。
- 亚全切除或活检患者辅助放疗的获益在多因素分析中未达统计学显著。
核心结论
- 辅助外照射放疗可能对老年WHO III级脑膜瘤全切除患者无生存获益。
研究设计与样本
- 回顾性队列研究,使用美国国家癌症数据库,纳入254例老年(>60岁)病理确诊WHO III级脑膜瘤手术患者。
主要发现
- 254例中151例(58.4%)接受手术+放疗,103例(41.6%)仅手术。
- 5年相对生存率辅助放疗组57.8%(95%CI 38.7%-85.4%),无放疗组38.1%(95%CI 21.9%-55.9%)。
- 单因素(P=0.011)和多因素分析(AHR 0.663,95%CI 0.449-0.978,P=0.038)辅助放疗与更长OS相关。
- 倾向评分匹配后辅助放疗未显著改善OS(P=0.271)。
- 全切除患者辅助放疗未改善OS(AHR 0.764,95%CI 0.434-1.344,P=0.350);亚全切除或活检患者多因素分析AHR 0.594(95%CI 0.337-1.046,P=0.071)。
临床怎么用
- 老年WHO III级脑膜瘤全切除后辅助放疗的生存获益不明确,需个体化决策。
局限性
- 倾向评分匹配后辅助放疗的生存获益未达统计学显著,提示存在混杂因素。
- 亚全切除或活检患者辅助放疗的多因素分析未达统计学显著(P=0.071)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The benefit of adjuvant radiotherapy (RT) is uncertain in elderly patients diagnosed with World Health Organization (WHO) grade III meningiomas. METHODS: The US National Cancer Database was used to identify elderly patients (aged over 60) with histologically confirmed WHO grade III meningiomas who underwent surgery with or without adjuvant external beam RT. Overall survival (OS) was evaluated by Kaplan-Meier analysis, multivariable Cox proportional hazard models, and propensity score-matched analysis. RESULTS: Among the 254 patients who met inclusion criteria, 151 (58.4%) underwent surgery followed by RT and 103 (41.6%) surgery without RT. The 5-year relative survival rate was 57.8% (95% confidence interval [CI], 38.7%-85.4%) in the adjuvant RT group and 38.1% (95% CI, 21.9%-55.9%) in the group without RT when compared with age- and gender-matched US population. Adjuvant RT was associated with longer OS on both univariate (P = 0.011) and multivariable analyses (adjusted hazard ratio [AHR], 0.663; 95% CI, 0.449-0.978; P = 0.038). However, adjuvant RT did not significantly improve OS in a propensity score-matched analysis (P = 0.271) after matching the 2 cohorts on age, race, comorbidity, extent of resection, and tumor size. In patients who underwent subtotal resection or biopsy (n = 106), adjuvant RT significantly benefited OS on univariate analysis (P = 0.023), but did not show statistically significant benefit on multivariate analysis (AHR, 0.594; 95% CI, 0.337-1.046; P = 0.071). Adjuvant RT was not associated with improved OS in the elderly patients who underwent gross total resection (AHR, 0.764; 95% CI, 0.434-1.344; P = 0.350). CONCLUSION: Adjuvant external beam RT may not provide any survival benefit for elderly patients with WHO grade III meningioma after gross total resection.
引用
- Zhou H, Bai HX, Chan L, et al. Survival Benefit of Adjuvant Radiotherapy in Elderly Patients with WHO Grade III Meningioma. World Neurosurg. 2019. PMID: 31356979. doi:10.1016/j.wneu.2019.07.140
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。